Leland Shawn 4
4 · Elevation Oncology, Inc. · Filed Feb 16, 2022
Insider Transaction Report
Form 4
Leland Shawn
DirectorPresident, CEO
Transactions
- Award
Employee Stock Option (Right to Buy)
2022-02-14+186,500→ 186,500 totalExercise: $3.78Exp: 2032-02-13→ Common Stock (186,500 underlying)
Footnotes (1)
- [F1]The stock option vests as to 25% of the total shares on February 10, 2023, and thereafter vests as to 1/48 of the total shares monthly until fully vested, subject to the Reporting Person's provision of service to the Issuer on each vesting date and is subject to acceleration in the event of a change in control of the Issuer.